press the down arrow to open sub-menu.
February 11, 2025
Join the Therapeutics Alliances team on Tuesday, February 11, 2025, at 12 pm ET for an informational webinar about the Therapeutics Alliances program and how to apply.
NYU Langone’s Therapeutics Alliances (TA) is sponsoring up to 15 one-year translational grants aimed at supporting projects focused on advancing innovative preclinical research through early-stage drug target selection, drug target validation, or hit-to-lead compound screening. Clinical potential, target druggability, and therapeutic modality will be considered during assessment, with funding decisions based on helping accelerate new therapeutics to the clinic. TA will not consider funding basic science within the scope of this RFP.
Projects will be evaluated for funding by the TA team and external industry experts with confidentiality maintained during review and assessment.